1. The primary efficacy outcome of symptomatic and asymptomatic venous thromboembolism was significantly lower in the rivaroxaban group (3.14%) compared ...
1. The primary efficacy outcome of symptomatic and asymptomatic venous thromboembolism was significantly lower in the rivaroxaban group (3.14%) compared ...
1. In patients with atrial fibrillation over 65, treatment with rivaroxaban compared to apixaban was associated with a significantly increased ...
![siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]](https://2minutemedicine-wpengine.netdna-ssl.com/wp-content/uploads/2015/04/clot-CCWiki-350x250.jpg)
1. Therapeutic anticoagulation with rivaroxaban or enoxaparin did not improve clinical outcomes and increased bleeding compared with prophylactic anticoagulation. 2. ...
1. Patients who received rivaroxaban had a statistically significantly longer mean time until occurrence of a major clinical event compared ...
1. Patients who received rivaroxaban had a statistically significantly longer mean time until occurrence of a major clinical event compared ...
1. Microbleeds increase risk of intracerebral hemorrhage, ischemic stroke, recurrent stroke, and mortality. 2. Microbleeds do not appear to influence ...
1. In this observational study, patients who received one of three direct oral anticoagulants (DOACs) were significantly less likely to ...
1. After successful transcatheter aortic valve replacement, compared to an anti-platelet based strategy, patients that received an anti-coagulation strategy including ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.